Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity

BACKGROUND: A recombinant Mycobacterium bovis BCG (rBCG) vector expressing HIV transgenes is an attractive candidate as a dual vaccine against HIV and TB. However, pre-existing immune responses to mycobacteria may influence immune responses to rBCG. We analyzed data from a rhesus rBCG trial to deter...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Vaccine
Asıl Yazarlar: Korioth-Schmitz, Birgit, Perley, Casey C., Sixsmith, Jaimie D., Click, Eva M., Lee, Sunhee, Letvin, Norman L., Frothingham, Richard
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4600653/
https://ncbi.nlm.nih.gov/pubmed/26192357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.07.010
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller